FDA Investigator Jeffrey A Sincek

Jeffrey A Sincek has inspections in 3 countries as of 25 Oct 2023. Jeffrey A Sincek has collaborated with a combinined 3326 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
306
Last Inspection Date:
25 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, United Kingdom of Great Britain and Northern Ireland, Canada
Co-Investigator(s):
Abraham M Maekele, Allison C Hunter, Allison E Sincek, Allison M Scheck, Amber M Capello Jones, Amy L Mccarthy, Andrew J Barrowcliff, Andrew J Lang, Andrew Saunders, Andria L Kuhlman, Angela E Glenn, Angela Mock, Ashley R Karns, Bailey A Uetrecht, Barbara A Gullick, Barbara J Holladay, Benjamin D Shuler, Benjamin J Dastoli, Benjamin P Stewart, Beverly A Thomas, Brian D Rogers, Brian M Campbell, Brian P Putz, Bryan J Love, Bryce A Hammer, Carl A Huffman, III, Carlos Hruiz Nunez, Catherine D Djordjevic, Charles C Conn, III, Charles Cconn Lii, Charles M Spyr, Chiaochun J Wang, Christian L Witkovskie, Christina L Bigham, Christine E Kelley, Christopher C Wilcox, Christopher D Snyder, Christopher T Middendorf, Clinton D Priestley, Cody W, Craig P Seaborn, Cynthia T Cain, Darren S Morgan, David L Craft, Deborah M Mcgee, Delkis J Caycedo, Dell S Moller, Dennis E Swartz, Diane M Gubernot, Diane R Mcdaniel, Djamila Harouaka, Don A Leeseberg, Dorathy M Eischen, Edward R Kay, Elizabeth A Laudig, Elizabeth Ll Edwards, Emily E Krumel, Emma A Nesbit, Emmanuel A Dimaano, Jr, Eric S Pittman, Eric T Santomieri, Evan M Kupper, Frederick M Lochner, George G Calafactor, George T Allen, Jr, Gilbert J Heidenblut, Green, Guy W Cartwright, Helen B Ricalde, Holly J Wilson, Hugh M Mcclure, II, Jaclyn N Munsch, Jacob G Lutz, Jacqueline M Bowling, James E Frye, James G Marsh, Jason D Werne, Javonica F Penn, Jdouglas Park, Jeanne F Broderick, Jennifer A Pruden, Jennifer L Gustavus, Jennifer M Heitz, Jessica M Monteiro, Jessica M Wooten, Jocelyn T Ramos, John A Hall, John D Jaworski, John D Mays, John E Russell, Jonathan A Ferguson, Joohi Castelvetere, Joshua P Wireman, Joshua S Hoeh, Joshua S Hunt, Karen M Kondas, Karen R Smallwood, Kathryn J Mccarty, Keith J Mason, Kelli Wilkinson, Kimberly A Joseph, Kirk A Dymbrowski, Klein, Lauren N Howard, Lauren N Smith, Lawrence J Stringer, LCDR Matthew J Morrison, Leonard Pesetsky, Leslie R Clark, Lindsey M Schwierjohann, Lisa M Marko, Lori A Holmquist, Lorraine L Chavis, Louis G An, M Patriciaurphy Murphy, Malik S Qaiser, Margaret A Foster, Maribeth G Niesen, Maricelys Mercado, Mark E Parmon, Mary B Sheets, Mary E Storch, Mary P Murphy, Maryam Tabatabaie, Matt D Suedkamp, Matthew B Casale, Matthew H Pitts, Michael A Charles, Michael C Ireland, Michael D Thatcher, Michael E Campbell, Michael E Cimaglio, Michael E Clark, Michael K Larson, Michael P Sheehan, Michelle Hawkins, Minerva Rogers, Mpris Inspector, Myra K Casey, Nadeem I Chaudhry, Nancy L Neiger, Nicholas L Paulin, Normica G Facey, Paul A Licata, Paula J Bretz, Payne, Peter R Lenahan, Philip S Woodward, Phillip M Pontikos, Pifer, Rachel T Evans, Rebecca Clark, Richard W Berning, Robert E Davis, Robert G Antonsen, Jr, Robert Rodriguez, Rosanna M Goodrich, Rterry Bolen, Samuel A Hamblin, Sarah E Rhoades, Sarah Forney, Sarah L Clark, Scotty L Hargrave, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Susan M Miller, Susan M Taylor, Suyang Qin, Suzie L Kent, Talmane J Fisher, Tania E Vizcaino, Ted L Anderson, Terri L Jones, Theresa C Klaman, Thomas C Woods, Thomas J Prigge, Thomas W Nojek, Toni S Sturgis, Tracey L Harris, Travis E Chapman, Tyra S Wisecup, Ucheabuchi C Chudi Nwankwor, Vipulchandra N Dholakia, William A Warnick, William D Bassett, Jr, Zachary L Miller, Zhigang Sun, PhD

Jeffrey A Sincek's Documents

Publish Date Document Type Title
July, 2002 FDA 483 Selective Med Components, Inc. - Form 483, 2002-07-16
December, 2000 FDA 483 Bigmar Pharmaceuticals Inc - Form 483, 2000-12-06
July, 2002 FDA 483 Response Spectramed LLC - Form 483R, 2002-07-30
August, 2002 EIR E Med Future Inc - EIR, 2002-08-28
March, 2001 FDA 483 Control-X Medical Inc - Form 483, 2001-03-28
December, 2002 EIR West-Ward Columbus Inc. - EIR, 2002-12-06
August, 2002 FDA 483 E Med Future Inc - Form 483, 2002-08-28
December, 2002 FDA 483 West-Ward Columbus Inc. - Form 483, 2002-12-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more